|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 540 for Nf1

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.041s

Categories

Category: Publication
« show all
Type Details Score
Publication
10442636 | J:56902
First Author: Gutmann DH
Year: 1999
Journal: Oncogene
Title: Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
Volume: 18
Issue: 31
Pages: 4450-9
•
•
•
•
•
Publication
23578956 | J:331298
First Author: O'Brien DE
Year: 2013
Journal: J Pain
Title: Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1.
Volume: 14
Issue: 6
Pages: 628-37
•
•
•
•
•
Publication
10844550 | J:62818
First Author: Atit RP
Year: 2000
Journal: J Invest Dermatol
Title: The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.
Volume: 114
Issue: 6
Pages: 1093-100
•
•
•
•
•
Publication
30348677 | J:269990
First Author: Chen Z
Year: 2019
Journal: Cancer Discov
Title: Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway.
Volume: 9
Issue: 1
Pages: 114-129
•
•
•
•
•
Publication
7926784 | J:18048
First Author: Brannan CI
Year: 1994
Journal: Genes Dev
Title: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
Volume: 8
Issue: 9
Pages: 1019-29
•
•
•
•
•
Publication
15886874 | J:105408
First Author: Ozerdem U
Year: 2004
Journal: Angiogenesis
Title: Targeting neovascular pericytes in neurofibromatosis type 1.
Volume: 7
Issue: 4
Pages: 307-11
•
•
•
•
•
Publication
30478082 | J:274104
First Author: Li XX
Year: 2019
Journal: G3 (Bethesda)
Title: Conditional Inactivation of Nf1 and Pten in Schwann Cells Results in Abnormal Neuromuscular Junction Maturation.
Volume: 9
Issue: 1
Pages: 297-303
•
•
•
•
•
Publication
9608530 | J:47680
First Author: Vogel KS
Year: 1998
Journal: Mol Cell Neurosci
Title: Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin.
Volume: 11
Issue: 1-2
Pages: 19-28
•
•
•
•
•
Publication
20826448 | J:165138
First Author: Brown JA
Year: 2010
Journal: Hum Mol Genet
Title: Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
Volume: 19
Issue: 22
Pages: 4515-28
•
•
•
•
•
Publication
9878702 | J:51953
First Author: Rizvi TA
Year: 1999
Journal: Brain Res
Title: Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.
Volume: 816
Issue: 1
Pages: 111-23
•
•
•
•
•
Publication
34880260 | J:316881
First Author: Chatterjee J
Year: 2021
Journal: Nat Commun
Title: Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia.
Volume: 12
Issue: 1
Pages: 7122
•
•
•
•
•
Publication
28629962 | J:249796
 
First Author: Weiss JB
Year: 2017
Journal: Behav Brain Res
Title: Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice.
Volume: 332
Pages: 337-342
•
•
•
•
•
Publication
14724565 | J:88366
First Author: Huang Y
Year: 2004
Journal: Oncogene
Title: Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Volume: 23
Issue: 2
Pages: 368-78
•
•
•
•
•
Publication
20551058 | J:162482
First Author: Warrington NM
Year: 2010
Journal: Cancer Res
Title: Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.
Volume: 70
Issue: 14
Pages: 5717-27
•
•
•
•
•
Publication
20233971 | J:162828
First Author: Staser K
Year: 2010
Journal: Blood
Title: Mast cells and the neurofibroma microenvironment.
Volume: 116
Issue: 2
Pages: 157-64
•
•
•
•
•
Publication
20600672 | J:165209
First Author: Kim KY
Year: 2010
Journal: Neuroscience
Title: Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.
Volume: 170
Issue: 1
Pages: 178-88
•
•
•
•
•
Publication
23624918 | J:212366
First Author: Chen YH
Year: 2014
Journal: Oncogene
Title: The molecular and cell biology of pediatric low-grade gliomas.
Volume: 33
Issue: 16
Pages: 2019-26
•
•
•
•
•
Publication
17510408 | J:121729
First Author: Sandsmark DK
Year: 2007
Journal: Cancer Res
Title: Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes.
Volume: 67
Issue: 10
Pages: 4790-9
•
•
•
•
•
Publication
32736084 | J:300564
 
First Author: Elmadany N
Year: 2020
Journal: Neurobiol Dis
Title: Neurofibromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.
Volume: 144
Pages: 105030
•
•
•
•
•
Publication
11988578 | J:76359
First Author: Zhu Y
Year: 2002
Journal: Science
Title: Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
Volume: 296
Issue: 5569
Pages: 920-2
•
•
•
•
•
Publication
12118376 | J:78079
First Author: King D
Year: 2002
Journal: Oncogene
Title: Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
Volume: 21
Issue: 32
Pages: 4978-82
•
•
•
•
•
Publication
10591653 | J:58877
First Author: Vogel KS
Year: 1999
Journal: Science
Title: Mouse tumor model for neurofibromatosis type 1.
Volume: 286
Issue: 5447
Pages: 2176-9
•
•
•
•
•
Publication
17208258 | J:117442
First Author: Garza R
Year: 2007
Journal: Mutat Res
Title: A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
Volume: 615
Issue: 1-2
Pages: 98-110
•
•
•
•
•
Publication
17875698 | J:124875
First Author: Warrington NM
Year: 2007
Journal: Cancer Res
Title: Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Volume: 67
Issue: 18
Pages: 8588-95
•
•
•
•
•
Publication
27791021 | J:238800
First Author: Deraredj Nadim W
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Volume: 113
Issue: 43
Pages: 12310-12315
•
•
•
•
•
Publication
28057529 | J:249635
 
First Author: Weiss JB
Year: 2017
Journal: Behav Brain Res
Title: Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice.
Volume: 321
Pages: 148-156
•
•
•
•
•
Publication
10594763 | J:59045
First Author: Mashour GA
Year: 1999
Journal: J Invest Dermatol
Title: Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA.
Volume: 113
Issue: 6
Pages: 1133-4
•
•
•
•
•
Publication
23762458 | J:203309
First Author: Wozniak DF
Year: 2013
Journal: PLoS One
Title: Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.
Volume: 8
Issue: 6
Pages: e66024
•
•
•
•
•
Publication
21956219 | J:226592
First Author: El-Hoss J
Year: 2012
Journal: J Bone Miner Res
Title: A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
Volume: 27
Issue: 1
Pages: 68-78
•
•
•
•
•
Publication
38258905 | J:345587
 
First Author: Raut NG
Year: 2024
Journal: JCI Insight
Title: Schwann cells modulate nociception in neurofibromatosis 1.
Volume: 9
Issue: 2
•
•
•
•
•
Publication
27333032 | J:240370
 
First Author: Patel AV
Year: 2016
Journal: EBioMedicine
Title: An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.
Volume: 9
Pages: 110-119
•
•
•
•
•
Publication
15652750 | J:95933
First Author: Ling BC
Year: 2005
Journal: Cancer Cell
Title: Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.
Volume: 7
Issue: 1
Pages: 65-75
•
•
•
•
•
Publication
25070947 | J:216219
First Author: Anastasaki C
Year: 2014
Journal: Hum Mol Genet
Title: Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
Volume: 23
Issue: 25
Pages: 6712-21
•
•
•
•
•
Publication
12077339 | J:77208
First Author: Bajenaru ML
Year: 2002
Journal: Mol Cell Biol
Title: Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.
Volume: 22
Issue: 14
Pages: 5100-13
•
•
•
•
•
Publication
25788518 | J:221342
First Author: Anastasaki C
Year: 2015
Journal: Hum Mol Genet
Title: Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Volume: 24
Issue: 12
Pages: 3518-28
•
•
•
•
•
Publication
15622533 | J:96293
First Author: Bajenaru ML
Year: 2005
Journal: Ann Neurol
Title: Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
Volume: 57
Issue: 1
Pages: 119-27
•
•
•
•
•
Publication
25184332 | J:223265
First Author: White S
Year: 2014
Journal: PLoS One
Title: Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.
Volume: 9
Issue: 9
Pages: e106767
•
•
•
•
•
Publication
24232507 | J:318855
First Author: Brosius SN
Year: 2014
Journal: Acta Neuropathol
Title: Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.
Volume: 127
Issue: 4
Pages: 573-91
•
•
•
•
•
Publication
25446898 | J:217465
First Author: Chen Z
Year: 2014
Journal: Cancer Cell
Title: Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.
Volume: 26
Issue: 5
Pages: 695-706
•
•
•
•
•
Publication
8622964 | J:108871
First Author: Verchere CB
Year: 1996
Journal: Proc Natl Acad Sci U S A
Title: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
Volume: 93
Issue: 8
Pages: 3492-6
•
•
•
•
•
Publication
12427839 | J:109211
First Author: Rizvi TA
Year: 2002
Journal: J Neurosci
Title: A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve.
Volume: 22
Issue: 22
Pages: 9831-40
•
•
•
•
•
Publication
16267007 | J:102692
First Author: Dasgupta B
Year: 2005
Journal: Cancer Res
Title: Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Volume: 65
Issue: 21
Pages: 9843-50
•
•
•
•
•
Publication
25246427 | J:264174
First Author: Kaul A
Year: 2015
Journal: Neuro Oncol
Title: The impact of coexisting genetic mutations on murine optic glioma biology.
Volume: 17
Issue: 5
Pages: 670-7
•
•
•
•
•
Publication
29787563 | J:263536
First Author: Pan Y
Year: 2018
Journal: PLoS One
Title: Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.
Volume: 13
Issue: 5
Pages: e0190001
•
•
•
•
•
Publication
28525381 | J:264176
First Author: Solga AC
Year: 2017
Journal: Oncotarget
Title: The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Volume: 8
Issue: 29
Pages: 47206-47215
•
•
•
•
•
Publication
21896734 | J:176586
First Author: Banerjee S
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.
Volume: 108
Issue: 38
Pages: 15996-6001
•
•
•
•
•
Publication
18089649 | J:130856
First Author: Diwakar G
Year: 2008
Journal: J Cell Sci
Title: Neurofibromin as a regulator of melanocyte development and differentiation.
Volume: 121
Issue: Pt 2
Pages: 167-77
•
•
•
•
•
Publication
26272820 | J:226180
First Author: Chen YH
Year: 2015
Journal: Genes Dev
Title: Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways.
Volume: 29
Issue: 16
Pages: 1677-82
•
•
•
•
•
Publication
21963652 | J:178468
First Author: Brown JA
Year: 2011
Journal: Exp Neurol
Title: PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.
Volume: 232
Issue: 2
Pages: 333-8
•
•
•
•
•
Publication
11279521 | J:68489
First Author: Costa RM
Year: 2001
Journal: Nat Genet
Title: Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1.
Volume: 27
Issue: 4
Pages: 399-405
•
•
•
•
•
Publication
11407944 | J:70651
First Author: Shannon KM
Year: 2001
Journal: Semin Cancer Biol
Title: Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse.
Volume: 11
Issue: 3
Pages: 191-200
•
•
•
•
•
Publication
8585954 | J:46032
 
First Author: Largaespada DA
Year: 1996
Journal: Curr Top Microbiol Immunol
Title: The neurofibromatosis type 1 (NF1) tumor suppressor gene and myeloid leukemia.
Volume: 211
Pages: 233-9
•
•
•
•
•
Publication
17383899 | J:122677
First Author: Banerjee D
Year: 2007
Journal: Neuroimage
Title: Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo.
Volume: 35
Issue: 4
Pages: 1434-7
•
•
•
•
•
Publication
38308315 | J:345054
First Author: Chatterjee J
Year: 2024
Journal: Acta Neuropathol Commun
Title: Brain injury drives optic glioma formation through neuron-glia signaling.
Volume: 12
Issue: 1
Pages: 21
•
•
•
•
•
Publication
22918885 | J:191804
First Author: Patmore DM
Year: 2012
Journal: Cancer Res
Title: In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.
Volume: 72
Issue: 20
Pages: 5317-27
•
•
•
•
•
Publication
11246230 | J:80411
First Author: Bajenaru ML
Year: 2001
Journal: Glia
Title: Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.
Volume: 33
Issue: 4
Pages: 314-23
•
•
•
•
•
Publication
16651634 | J:108591
First Author: Wu J
Year: 2006
Journal: Am J Pathol
Title: Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma.
Volume: 168
Issue: 5
Pages: 1686-96
•
•
•
•
•
Publication
23318450 | J:204871
First Author: Solga AC
Year: 2014
Journal: Oncogene
Title: NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Volume: 33
Issue: 3
Pages: 289-99
•
•
•
•
•
Publication
8353485 | J:12590
First Author: Bernards A
Year: 1993
Journal: Hum Mol Genet
Title: Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments.
Volume: 2
Issue: 6
Pages: 645-50
•
•
•
•
•
Publication
23522726 | J:202145
First Author: Oliver JA
Year: 2013
Journal: Mol Immunol
Title: The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes.
Volume: 55
Issue: 3-4
Pages: 292-302
•
•
•
•
•
Publication
7920653 | J:18542
First Author: Jacks T
Year: 1994
Journal: Nat Genet
Title: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
Volume: 7
Issue: 3
Pages: 353-61
•
•
•
•
•
Publication
36351971 | J:334781
First Author: Ottenhoff MJ
Year: 2022
Journal: Sci Rep
Title: Cerebellum-dependent associative learning is not impaired in a mouse model of neurofibromatosis type 1.
Volume: 12
Issue: 1
Pages: 19041
•
•
•
•
•
Publication
18984165 | J:147614
First Author: Cui Y
Year: 2008
Journal: Cell
Title: Neurofibromin regulation of ERK signaling modulates GABA release and learning.
Volume: 135
Issue: 3
Pages: 549-60
•
•
•
•
•
Publication
22399775 | J:182728
First Author: Li Y
Year: 2012
Journal: J Neurosci
Title: Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants.
Volume: 32
Issue: 10
Pages: 3529-39
•
•
•
•
•
Publication
31545171 | J:284515
   
First Author: Robinson JE
Year: 2019
Journal: Elife
Title: Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.
Volume: 8
•
•
•
•
•
Publication
18242512 | J:131915
First Author: Zheng H
Year: 2008
Journal: Cancer Cell
Title: Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.
Volume: 13
Issue: 2
Pages: 117-28
•
•
•
•
•
Publication
19427294 | J:149832
First Author: Le LQ
Year: 2009
Journal: Cell Stem Cell
Title: Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.
Volume: 4
Issue: 5
Pages: 453-63
•
•
•
•
•
Publication
20624961 | J:162376
First Author: Shilyansky C
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.
Volume: 107
Issue: 29
Pages: 13141-6
•
•
•
•
•
Publication
- | J:329328
       
First Author: Skoulakis EMC
Year: 2022
Title: An Interspecies Approach to Model Differential Cognitive Effects of Specific Neurofibromin I Mutations.
•
•
•
•
•
Publication
10586246 | J:59850
 
First Author: Rosenbaum T
Year: 1999
Journal: Ann N Y Acad Sci
Title: Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Volume: 883
Pages: 203-14
•
•
•
•
•
Publication
12573431 | J:81524
First Author: Dasgupta B
Year: 2003
Journal: Curr Opin Genet Dev
Title: Neurofibromatosis 1: closing the GAP between mice and men.
Volume: 13
Issue: 1
Pages: 20-7
•
•
•
•
•
Publication
18213578 | J:130164
First Author: Roth TM
Year: 2008
Journal: Dev Dyn
Title: Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
Volume: 237
Issue: 2
Pages: 513-24
•
•
•
•
•
Publication
22901811 | J:187986
First Author: Wang Y
Year: 2012
Journal: Cell
Title: ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.
Volume: 150
Issue: 4
Pages: 816-30
•
•
•
•
•
Publication
7477259 | J:29825
First Author: Henkemeyer M
Year: 1995
Journal: Nature
Title: Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein.
Volume: 377
Issue: 6551
Pages: 695-701
•
•
•
•
•
Publication
32358581 | J:291790
First Author: Guo X
Year: 2020
Journal: Nat Commun
Title: Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth.
Volume: 11
Issue: 1
Pages: 2177
•
•
•
•
•
Publication
35311647 | J:322614
   
First Author: Patritti Cram J
Year: 2022
Journal: Elife
Title: P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Volume: 11
•
•
•
•
•
Publication
31445228 | J:293644
 
First Author: Rizwan G
Year: 2019
Journal: Epilepsy Res
Title: Increased seizure susceptibility in a mouse model of neurofibromatosis type 1.
Volume: 156
Pages: 106190
•
•
•
•
•
Publication
16835260 | J:112050
First Author: Yang FC
Year: 2006
Journal: Hum Mol Genet
Title: Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Volume: 15
Issue: 16
Pages: 2421-37
•
•
•
•
•
Publication
10498620 | J:57842
First Author: Mahgoub N
Year: 1999
Journal: Blood
Title: In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.
Volume: 94
Issue: 7
Pages: 2469-76
•
•
•
•
•
Publication
23863460 | J:202235
First Author: Sharma R
Year: 2013
Journal: Hum Mol Genet
Title: Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
Volume: 22
Issue: 23
Pages: 4818-28
•
•
•
•
•
Publication
18442999 | J:137662
First Author: Lasater EA
Year: 2008
Journal: Hum Mol Genet
Title: Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.
Volume: 17
Issue: 15
Pages: 2336-44
•
•
•
•
•
Publication
35589737 | J:324999
First Author: Anastasaki C
Year: 2022
Journal: Nat Commun
Title: Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.
Volume: 13
Issue: 1
Pages: 2785
•
•
•
•
•
Publication
19727076 | J:152381
First Author: Lauchle JO
Year: 2009
Journal: Nature
Title: Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras.
Volume: 461
Issue: 7262
Pages: 411-4
•
•
•
•
•
Publication
24997609 | J:227603
First Author: de la Croix Ndong J
Year: 2014
Journal: Nat Med
Title: Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.
Volume: 20
Issue: 8
Pages: 904-10
•
•
•
•
•
Publication
23221341 | J:194157
First Author: Jessen WJ
Year: 2013
Journal: J Clin Invest
Title: MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.
Volume: 123
Issue: 1
Pages: 340-7
•
•
•
•
•
Publication
1946382 | J:31498
First Author: Gutmann DH
Year: 1991
Journal: Proc Natl Acad Sci U S A
Title: Identification of the neurofibromatosis type 1 gene product.
Volume: 88
Issue: 21
Pages: 9658-62
•
•
•
•
•
Publication
7633452 | J:25208
First Author: Danglot G
Year: 1995
Journal: Hum Mol Genet
Title: Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene.
Volume: 4
Issue: 5
Pages: 915-20
•
•
•
•
•
Publication
19074905 | J:142234
First Author: Daginakatte GC
Year: 2008
Journal: Cancer Res
Title: Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
Volume: 68
Issue: 24
Pages: 10358-66
•
•
•
•
•
Publication
16893911 | J:114925
First Author: Wu X
Year: 2006
Journal: Hum Mol Genet
Title: Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.
Volume: 15
Issue: 19
Pages: 2837-45
•
•
•
•
•
Publication
15804420 | J:104976
First Author: Yu X
Year: 2005
Journal: Bone
Title: Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
Volume: 36
Issue: 5
Pages: 793-802
•
•
•
•
•
Publication
25786243 | J:229201
First Author: Rhodes SD
Year: 2015
Journal: PLoS One
Title: Dystrophic spinal deformities in a neurofibromatosis type 1 murine model.
Volume: 10
Issue: 3
Pages: e0119093
•
•
•
•
•
Publication
21439418 | J:172512
First Author: Zhang W
Year: 2011
Journal: Bone
Title: Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.
Volume: 48
Issue: 6
Pages: 1378-87
•
•
•
•
•
Publication
21352477 | J:185707
First Author: van der Vaart T
Year: 2011
Journal: Genes Brain Behav
Title: Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.
Volume: 10
Issue: 4
Pages: 404-9
•
•
•
•
•
Publication
17236191 | J:156102
First Author: Nebesio TD
Year: 2007
Journal: Glia
Title: Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Volume: 55
Issue: 5
Pages: 527-36
•
•
•
•
•
Publication
20160346 | J:158570
First Author: Lasater EA
Year: 2010
Journal: J Clin Invest
Title: Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.
Volume: 120
Issue: 3
Pages: 859-70
•
•
•
•
•
Publication
19574548 | J:164937
First Author: Xu J
Year: 2009
Journal: Circ Res
Title: Cardiomyocyte-specific loss of neurofibromin promotes cardiac hypertrophy and dysfunction.
Volume: 105
Issue: 3
Pages: 304-11
•
•
•
•
•
Publication
32810864 | J:295936
First Author: Vasiljevski ER
Year: 2020
Journal: PLoS One
Title: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
Volume: 15
Issue: 8
Pages: e0237097
•
•
•
•
•
Publication
22307743 | J:211765
First Author: Alanne MH
Year: 2012
Journal: J Cell Biochem
Title: Phenotypic characterization of transgenic mice harboring Nf1+/- or Nf1-/- osteoclasts in otherwise Nf1+/+ background.
Volume: 113
Issue: 6
Pages: 2136-46
•
•
•
•
•
Publication
20124472 | J:157155
First Author: Banerjee S
Year: 2010
Journal: Cancer Res
Title: The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.
Volume: 70
Issue: 4
Pages: 1356-66
•
•
•
•
•
Publication
21319287 | J:215873
First Author: Wu J
Year: 2012
Journal: Pediatr Blood Cancer
Title: Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Volume: 58
Issue: 2
Pages: 173-80
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom